Key Facts
- CAS
- 2538014-94-5
- Molecular Weight (MW)
- ≈4094 g/mol
- Half-life
- ~110 hours (EuPort™ albumin-binding domain; weekly dosing)
- Unit
- mcg
- Administration Route
- Subcutaneous
- Frequency
- Weekly
- Last updated
- 12/14/2025
Overview
—
Protocol
- Dosage Range
- Investigational - dosage under evaluation in clinical trials
- Frequency
- Weekly
- Cycle
- Per study
- Administration Route
- Subcutaneous
- Reconstitution Guide
- Investigational - not yet established
Science
Mechanism of Action
Mechanism of action not fully established in publicly available sources.
Studies are being curated for this entry.
Suggest a studyBenefits
Therapeutic benefits not fully established.
Potential Side Effects
- Side effects not fully established.
References
References coming soon.
Suggest a reference